It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable prostate ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable ...

The SWOG S2302 Pragmatica-Lung trial, which broke new ground with its streamlined pragmatic design, unusually broad ...

A diagnosis identifies a patient’s health problem ... with non-investigator physicians during the course of the trial, the patients’ participation was not documented in any of their medical ...

It is a non-randomised, single-arm, open-label, multi-centre, diagnostic clinical trial of 64 Cu-SAR-bisPSMA positron emission tomography (PET) in participants with rising or detectable prostate ...

Plus, President Joe Biden’s cancer diagnosis. By Julia Jacobs I have ... could put him in prison for life. The trial this week will focus on the testimony of former employees and other witnesses ...

The win ratio is a method for analyzing a hierarchical composite outcome. It has been most widely used in randomized clinical trials (RCTs) in cardiovascular disease. We performed a review of ...